It was reported that methylene blue was utilized the first day of ecls (extra-corporeal life support) for "vasoplegia syndrome" in an attempt to improve blood pressure and central hemodynamics.Forty eight hours after use, the water bath was tinged blue.The venous blood color was also noted to be much darker, with some blue discoloration noted on the venous tubing.The patient was without fever and responding favorably to ecls therapy.The patient was successfully removed from support on day five.(b)(4).
|
(b)(4).Maquet cardiopulmonary (b)(4) provides product failure investigation, analysis and corrective actions for the device described in this report.Based on the reported event and investigation, the reported event was caused by use that is beyond the usage described in our labeling and cleared intended use.A maquet territory manager explained to the clinician that methylene blue is contraindicated in the device ifu.He explained that methylene blue can cross the polyurethane heat exchanger and enter the water bath of the heat exchange device.Once in the water of the heat exchanger, methylene blue changes molecular configuration and cannot go back across the polyurethane heat exchanger back into the bloodstream.This occurs at a molecular and bacteriostatic level.This can alter the blood plasma level and concentration of the methylene blue for the patient.A supplemental medwatch will be submitted if additional information becomes available.
|